Hypoxia Enhances the Expression of RNASET2 in Human Monocyte-Derived Dendritic Cells: Role of PI3K/AKT Pathway

Abstract

Hypoxia is a key component of the tumor microenvironment (TME) and promotes not only tumor growth and metastasis, but also negatively affects infiltrating immune cells by impairing host immunity. Dendritic cells (DCs) are the most potent antigen-presenting cells and their biology is weakened in the TME in many ways, including the modulation of their viability. RNASET2 belongs to the T2 family of extracellular ribonucleases and, besides its nuclease activity, it exerts many additional functions. Indeed, RNASET2 is involved in several human pathologies, including cancer, and it is functionally relevant in the TME. RNASET2 functions are not restricted to cancer cells and its expression could be relevant also in other cell types which are important players in the TME, including DCs. Therefore, this study aimed to unravel the effect of hypoxia (2% O2) on the expression of RNASET2 in DCs. Here, we showed that hypoxia enhanced the expression and secretion of RNASET2 in human monocyte-derived DCs. This paralleled the HIF-1α accumulation and HIF-dependent and -independent signaling, which are associated with DCs’ survival/autophagy/apoptosis. RNASET2 expression, under hypoxia, was regulated by the PI3K/AKT pathway and was almost completely abolished by TLR4 ligand, LPS. Taken together, these results highlight how hypoxia- dependent and -independent pathways shape RNASET2 expression in DCs, with new perspectives on its implication for TME and, therefore, in anti-tumor immunity.

Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy

“…Similarly, hypoxia negatively affects DC cells function which is associated with HIF-1α accumulation and DC cells’ autophagy/apoptosis regulated by the PI3K/AKT pathway. 284 …”

Natural products of traditional Chinese medicine treat atherosclerosis by regulating inflammatory and oxidative stress pathways

“…Phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signaling pathways mainly influence the development of AS by regulating inflammatory immunity and chemokines. The PI3K/ AKT signaling pathway mediates dendritic cells to intervene in immune responses, thereby initiating inflammatory immunity (Monaci et al, 2021). Chemokines are also affected by the PI3K/ AKT signaling pathway, prompting inflammatory cell activation and the regulation of macrophage polarization.…”

Anti‐angiogenic therapy enhances cancer immunotherapy: Mechanism and clinical application

“…10,[34][35][36] Moreover, hypoxia plays a role in fostering an immunosuppressive tumor microenvironment, 37 also favoring cancer cell growth. 38,39 Emerging evidence supports an alternative effect of anti-angiogenic therapy by temporarily normalizing the aberrant structure of tumor vasculature, known as vascular normalization. [13][14][15] The tumor vessels are distinct from those in normal tissues and are characterized by excessive, dilated, tortuous, and hyperpermeable.…”